Gourt > Health > Pharmacy > Drugs and Medications > R > Rivastigmine
Rivastigmine tartrate (Exelon) is a medication developed and marketed by Novartis for the treatment of Alzheimer's disease and Dementia with Lewy bodies. The drug inhibits cholinesterase and butyrylcholinesterase and is designed for symptomatic treatment of early- to middle-stage Alzheimer's.
See also
More on [ Rivastigmine ]
Original paper Predictors of long-term treatment effect of rivastigmine in Alzheimerâs disease: a role for ... http://tinyurl.com/yjqtd8q
healthtopicsaz (Health Topics A-Z) Wed, 06 Jan 2010 04:54:29 -0000
Original paper Predictors of long-term treatment effect of rivastigmine in Alzheimer’s disease: a role for ... http://tinyurl.com/yjqtd8q
Alzheimer's Disease Information: Donepezil, galantamine, rivastigmine (review) and memantine for ...
tavraze (Tavish Raizel) Tue, 05 Jan 2010 15:11:41 -0000
Alzheimer's Disease Information: Donepezil, galantamine, rivastigmine (review) and memantine for ...
Exelon (rivastigmine tartrate) - Used to treat people with mild or moderate Alzheimer's disease (AD).
Meta Description: [ Learn about Exelon, a medication for the treatment of mild to moderate Alzheimer's disease. ]
Exelon Consumer Information - FDA - Patient FAQ in html format with a link to approved labeling in pdf format.
Meta Description: [ Consumer Information Sheet ]
Rivastigmine - Familydoctor.org - Information for patients in English and Spanish.
| è人ç´åçè¥è²¼ Transdermal Patch for Alzheimer's Disease and Parkinson's Disease Dementia | |
